vs

Side-by-side financial comparison of SunOpta Inc. (STKL) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

SunOpta Inc. is the larger business by last-quarter revenue ($205.4M vs $142.0M, roughly 1.4× Oncology Institute, Inc.). SunOpta Inc. runs the higher net margin — 0.4% vs -5.3%, a 5.7% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 16.6%). SunOpta Inc. produced more free cash flow last quarter ($12.1M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 7.4%).

SunOpta, Inc. is a multi-national food and mineral company headquartered in Eden Prairie, Minnesota and founded in 1973 in Canada.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

STKL vs TOI — Head-to-Head

Bigger by revenue
STKL
STKL
1.4× larger
STKL
$205.4M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+25.0% gap
TOI
41.6%
16.6%
STKL
Higher net margin
STKL
STKL
5.7% more per $
STKL
0.4%
-5.3%
TOI
More free cash flow
STKL
STKL
$9.9M more FCF
STKL
$12.1M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
7.4%
STKL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
STKL
STKL
TOI
TOI
Revenue
$205.4M
$142.0M
Net Profit
$816.0K
$-7.5M
Gross Margin
12.4%
Operating Margin
3.3%
-4.9%
Net Margin
0.4%
-5.3%
Revenue YoY
16.6%
41.6%
Net Profit YoY
113.1%
43.0%
EPS (diluted)
$0.01
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STKL
STKL
TOI
TOI
Q4 25
$142.0M
Q3 25
$205.4M
$136.6M
Q2 25
$191.5M
$119.8M
Q1 25
$201.6M
$104.4M
Q4 24
$193.9M
$100.3M
Q3 24
$175.9M
$99.9M
Q2 24
$169.5M
$98.6M
Q1 24
$184.4M
$94.7M
Net Profit
STKL
STKL
TOI
TOI
Q4 25
$-7.5M
Q3 25
$816.0K
$-16.5M
Q2 25
$4.4M
$-17.0M
Q1 25
$4.8M
$-19.6M
Q4 24
$-8.7M
$-13.2M
Q3 24
$-6.2M
$-16.1M
Q2 24
$-5.3M
$-15.5M
Q1 24
$2.9M
$-19.9M
Gross Margin
STKL
STKL
TOI
TOI
Q4 25
Q3 25
12.4%
Q2 25
14.8%
Q1 25
15.0%
Q4 24
10.9%
Q3 24
13.0%
Q2 24
12.5%
Q1 24
16.8%
Operating Margin
STKL
STKL
TOI
TOI
Q4 25
-4.9%
Q3 25
3.3%
-5.9%
Q2 25
5.5%
-9.4%
Q1 25
5.2%
-9.5%
Q4 24
1.4%
-11.9%
Q3 24
0.5%
-13.9%
Q2 24
1.2%
-16.6%
Q1 24
5.5%
-19.0%
Net Margin
STKL
STKL
TOI
TOI
Q4 25
-5.3%
Q3 25
0.4%
-12.1%
Q2 25
2.3%
-14.2%
Q1 25
2.4%
-18.8%
Q4 24
-4.5%
-13.1%
Q3 24
-3.5%
-16.1%
Q2 24
-3.1%
-15.7%
Q1 24
1.6%
-21.0%
EPS (diluted)
STKL
STKL
TOI
TOI
Q4 25
$-0.04
Q3 25
$0.01
$-0.14
Q2 25
$0.03
$-0.15
Q1 25
$0.04
$-0.21
Q4 24
$-0.08
$-0.14
Q3 24
$-0.05
$-0.18
Q2 24
$-0.04
$-0.17
Q1 24
$0.02
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STKL
STKL
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$2.2M
Total DebtLower is stronger
$250.8M
Stockholders' EquityBook value
$162.8M
$-15.7M
Total Assets
$694.1M
$164.7M
Debt / EquityLower = less leverage
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STKL
STKL
TOI
TOI
Q4 25
Q3 25
$2.2M
Q2 25
$2.2M
Q1 25
$2.3M
Q4 24
$1.6M
Q3 24
$2.9M
Q2 24
$3.2M
$9.9M
Q1 24
$1.5M
$29.8M
Total Debt
STKL
STKL
TOI
TOI
Q4 25
Q3 25
$250.8M
Q2 25
$263.3M
Q1 25
$260.6M
Q4 24
$265.2M
Q3 24
$289.9M
Q2 24
$303.1M
Q1 24
$258.8M
Stockholders' Equity
STKL
STKL
TOI
TOI
Q4 25
$-15.7M
Q3 25
$162.8M
$-12.3M
Q2 25
$159.8M
$-9.0M
Q1 25
$154.8M
$5.1M
Q4 24
$148.6M
$3.6M
Q3 24
$155.0M
$15.5M
Q2 24
$158.8M
$29.2M
Q1 24
$163.6M
$41.3M
Total Assets
STKL
STKL
TOI
TOI
Q4 25
$164.7M
Q3 25
$694.1M
$163.6M
Q2 25
$704.9M
$159.8M
Q1 25
$690.7M
$164.0M
Q4 24
$668.5M
$172.7M
Q3 24
$699.3M
$179.2M
Q2 24
$704.7M
$179.6M
Q1 24
$671.8M
$204.5M
Debt / Equity
STKL
STKL
TOI
TOI
Q4 25
Q3 25
1.54×
Q2 25
1.65×
Q1 25
1.68×
Q4 24
1.78×
Q3 24
1.87×
Q2 24
1.91×
Q1 24
1.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STKL
STKL
TOI
TOI
Operating Cash FlowLast quarter
$16.3M
$3.2M
Free Cash FlowOCF − Capex
$12.1M
$2.2M
FCF MarginFCF / Revenue
5.9%
1.5%
Capex IntensityCapex / Revenue
2.1%
0.7%
Cash ConversionOCF / Net Profit
20.03×
TTM Free Cash FlowTrailing 4 quarters
$36.4M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STKL
STKL
TOI
TOI
Q4 25
$3.2M
Q3 25
$16.3M
$-12.6M
Q2 25
$-4.5M
$-10.2M
Q1 25
$22.3M
$-5.0M
Q4 24
$33.1M
$4.2M
Q3 24
$17.2M
$819.0K
Q2 24
$-5.6M
$-15.7M
Q1 24
$5.3M
$-15.9M
Free Cash Flow
STKL
STKL
TOI
TOI
Q4 25
$2.2M
Q3 25
$12.1M
$-13.2M
Q2 25
$-9.2M
$-11.4M
Q1 25
$9.5M
$-5.3M
Q4 24
$24.0M
$2.4M
Q3 24
$11.7M
$417.0K
Q2 24
$-15.3M
$-17.5M
Q1 24
$-2.3M
$-16.5M
FCF Margin
STKL
STKL
TOI
TOI
Q4 25
1.5%
Q3 25
5.9%
-9.7%
Q2 25
-4.8%
-9.5%
Q1 25
4.7%
-5.1%
Q4 24
12.4%
2.4%
Q3 24
6.6%
0.4%
Q2 24
-9.0%
-17.7%
Q1 24
-1.2%
-17.4%
Capex Intensity
STKL
STKL
TOI
TOI
Q4 25
0.7%
Q3 25
2.1%
0.4%
Q2 25
2.5%
1.0%
Q1 25
6.3%
0.3%
Q4 24
4.7%
1.8%
Q3 24
3.2%
0.4%
Q2 24
5.7%
1.9%
Q1 24
4.1%
0.6%
Cash Conversion
STKL
STKL
TOI
TOI
Q4 25
Q3 25
20.03×
Q2 25
-1.03×
Q1 25
4.63×
Q4 24
Q3 24
Q2 24
Q1 24
1.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STKL
STKL

Beverages And Broths$161.4M79%
Fruit Snacks$40.9M20%
Ingredients$3.1M2%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons